Vale completes first sale of iron ore using blockchain technology with Nanjing Iron & Steel
Vale, one of the world’s largest mining companies, completed its first sale of iron ore using blockchain technology with Nanjing Iron & Steel Group International Trade Co., Ltd., a subsidiary of Nanjing Iron and Steel Co., Ltd. (NISCO) for a cargo of 176,000 tons of Brazilian Blend Fines (BRBF) from Teluk Rubiah Maritime Terminal, in Malaysia, to China.
Vale said this transaction is aligned with its strategy of becoming a more innovative and customer-centered company through greater integration with clients and partnering for the development of new solutions.
Vale also called it an important milestone towards the digitalization of the sales and trade process, bringing innovation to the traditional paper-intensive trade transactions and offering a better service to the clients as well as predictability in the steel value chain.
The Letter of Credit (LC) was issued through the Contour blockchain platform while the shipping documents and the electronic Bill of Lading were handled via essDOCS’ CargoDocs solution—with all actions carried out through a single, interfaced platform consolidated in Contour. The transaction also had the support from DBS Bank Ltd and Standard Chartered Bank Malaysia Berhad.
The integrated transaction enabled end-to-end security and transparency with real time visibility of the documentation to all stakeholders, drastically reducing the amount of emails and paperwork exchanged among the parties and providing enhanced user experience through access to a single solution to execute the trade.
Posted by AGORACOM-JC
at 3:08 PM on Friday, October 30th, 2020
Received geochemical results for sediments from two core holes at the Bonnie Claire Lithium Deposit in Nevada
Both drill holes contain intercepts of +1,000 ppm lithium and continue to show that results are consistent with those from prior drilling
Core hole BC2001C intersected 67 meters (220 feet) averaging 1209 ppm Li and contained a high of 1710 ppm Li. Core hole BC2002C contained a high of 1070 ppm Li
Vancouver, British Columbia–(October 30, 2020) –Iconic Minerals Ltd.(TSXV: ICM) (OTC Pink: BVTEF) (FSE: YQGB) (“Company” or “Iconic”) is pleased to announce that it has received geochemical results for sediments from two core holes at the Bonnie Claire Lithium Deposit in Nevada. Both drill holes contain intercepts of +1,000 ppm lithium and continue to show that results are consistent with those from prior drilling. Sediment geochemical analysis was done by ALS Chemex of Reno, Nevada.
Core hole BC2001C intersected 67 meters (220 feet) averaging 1209 ppm Li and contained a high of 1710 ppm Li. Core hole BC2002C contained a high of 1070 ppm Li. Occasional lighter colored sediments seen in the core may indicate some leaching of soluble elements is occurring. Water samples, highly diluted by added drill water, were taken from each core hole. The water samples were analyzed for dissolved lithium by Western Environmental Testing of Sparks, Nevada. Of the four samples taken the high for dissolved lithium was 38 ppm. The highest water sample taken in all of Iconic’s previous drilling at Bonnie Claire, with the exception of one non-repeatable sample, was 4.1 ppm Li. As a result of these encouraging results the water sampling was also taken in the RC drilling program. These samples were taken at rod changes after clearing the hole of drill water.
The RC (reverse circulation) drilling has now been completed. A total of four holes ranging from 61 to 109 meters (200 to 358 feet) were drilled to expand the resource and collect samples for metallurgy. Samples have been sent for testing to ALS Chemex of Reno Nevada for assaying. The drilling extended the current resource approximately 2,500 meters (8,200 feet) to the south.
The Bonnie Claire Lithium Property Characteristics:
The Property is located within Sarcobatus Valley that is approximately 30 km (19 miles) long and 20 km (12 miles) wide. Quartz-rich volcanic tuffs, that contain anomalous amounts of lithium, occur within and adjacent to the valley. Geochemical analysis of the local salt flats has yielded lithium values up to 340 ppm. The gravity low within the valley is 20 km (12 miles) long, and the current estimates of depth to basement rocks range from 600 to 1,200 meters (2,000 to 4,000 feet). The current claim block covers an area of 35 km2 (13.5 mi2) with potential to be underlain by lithium-rich sediments.
Richard Kern, Certified Professional Geologist (#11494) and CEO of Iconic is the Qualified Person who has prepared and reviewed this press release in accordance with NI 43-101 reporting standards.
On behalf of the Board of Directors
SIGNED: “Richard Kern“ Richard Kern, President and CEO
Contact: Keturah Nathe VP Corporate Development (604) 336-8614
The Company’s public documents may be accessed at www.sedar.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 7:13 AM on Friday, October 30th, 2020
Announced that early response from its interactive webinar with Amazon Web Services to showcase the Company’s Venue Tracing Solution to a global audience on October 29th is indicating great success
THE EVENT – MAXIMUM ATTENDANCE OF 1,000 ACHIEVED
THE RESPONSE – OVERWHELMING DIRECT INQUIRIES SPANNING THE WORLD
EVENT BUILDS ON AMAZON APPOINTMENT OF LOOP INSIGHTS TO PREFERRED PARTNER NETWORK INCLUDING 90% OF FORTUNE 100
Webinar achieved its maximum attendance of 1,000 viewers, with more than 88% of viewers remaining engaged through to the end of the final Q&A segment
Presentation ended at approximately 1:15 PM EST, and by 8:00 PM EST Loop had received over 100 direct inquiries from enterprise-level attendees spanning many different industries and countries
VANCOUVER, British Columbia, Oct. 30, 2020 — Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated contact tracing to the brick and mortar space, is pleased to announce that early response from its interactive webinar with Amazon Web Services to showcase the Company’s Venue Tracing Solution to a global audience on October 29th is indicating great success.
THE EVENT – MAXIMUM ATTENDANCE OF 1,000 ACHIEVED
Amazon Web Services (AWS) Principal Solutions Architect Mike Apted and Loop Insights CEO Rob Anson co-hosted the event to provide invitees with a first hand and interactive experience of Loop’s End-To-End Venue Tracing Platform.
The webinar was an open invitation to AWS and Loop partners from around the world from industries including but not limited to:
Airlines
Venue Owners
Sports & Entertainment Enterprises
Professional Sports Teams
Telecom
Government
The webinar achieved its maximum attendance of 1,000 viewers, with more than 88% of viewers remaining engaged through to the end of the final Q&A segment.
THE RESPONSE – OVERWHELMING DIRECT INQUIRIES SPANNING THE WORLD
The presentation ended at approximately 1:15 PM EST, and by 8:00 PM EST Loop had received over 100 direct inquiries from enterprise-level attendees spanning many different industries and countries. Loop Insights anticipates many more direct inquiries to be received in the coming days.
Loop Insights CEO Rob Anson stated, “We knew going into the webinar that interest in our Contactless Platform and Solutions was very high given the high-level nature of clients we had already announced leading up to it. These attendees, many of whom represent household name entities, were looking to us for solutions that can protect people, instill confidence in their customers and get their enterprises moving once again. Nonetheless, the response to the demonstration of our Contactless Venue Tracing Platform was simply incredible and even surpassed our expectations. We are optimistic that Loop Insights is establishing an identity as a global force in the contactless space and believe the responses will lead to significant business for Loop. We can’t thank Amazon Web Services enough for their continued support and partnership.”
EVENT BUILDS ON AMAZON APPOINTMENT OF LOOP INSIGHTS TO PREFERRED PARTNER NETWORK INCLUDING 90% OF FORTUNE 100
On June 8, 2020, Loop was accepted into Amazon Web Services Partner Network (APN), the global partner program for leading technology businesses from which more than 90% of Fortune 100 companies source their solutions and services.
Some of the benefits of the APN include networking opportunities to gain access to hundreds of ongoing AWS portfolios, as well as co-development projects and continued AWS resources that support product development, marketing, and sales.
With many, if not most AWS business accounts facing significant economic challenges requiring solutions that can safely and effectively re-start normalized operations and financial recovery, Loop’s APN status in conjunction with AWS position as a trusted source of solutions is expected to create continued significant interested in Loop’s Venue Tracing Platform.
LOOP INSIGHT VENUE TRACING PLATFORM IS BUILT AND SUPPORTED BY AWS CLOUD INFRASTRUCTURE
Loop’s Venue Tracing platform is clearly gaining recognition and third-party validation, including implementations with:
Major Las Vegas Hospitality Chains
University of Houston;
NCAA #VegasBubble; and
Most recently being accepted into the TELUS IoT Marketplace as “one of the most advanced IoT business solutions in the world”
Loop is also pleased to announce that it has secured The Depository Trust Company (DTC) eligibility for its shares traded in the United States under the symbol RAMCF. The Company’s common shares traded on the OTC Market in the United States, under the symbol “RAMCF” are Depository Trust Company (“DTC”) eligible, effective October 29, 2020. The DTC will facilitate electronic settlement of transfers of its common shares in the United States.
Rob Anson stated , “We are very pleased to have obtained DTC eligibility. Loop is registering its shares with DTC as a fundamental step towards establishing the Company with the American investment community. This electronic method of clearing securities expedites the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms. The DTC’s electronic settlement of our shares is critical to having an effective market.”
This press release is available on the Loop Insights Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/LoopInsights
About Loop Insights : Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network.
This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 6:04 PM on Thursday, October 29th, 2020
SPONSOR: Innocan Pharma Corporation (INNO:CSE) (IP4:FSE) Innocan has 3 fully operating divisions to address the market for Cannabis products. As a Cannabis investor, why limit yourself to a Company with just one specialty, when Innocan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products. In addition, the company filed an international patent application for a novel cannabis-based psoriasis treatment. This patent application makes claim of a topical pharmaceutical composition used to treat the symptoms of itching and inflammation associated with psoriasis.
“The global psoriasis drugs market is forecast to reach USD 39.00 Billion by 2027.
Could Cannabis Eliminate The High-Cost And High-Stakes Of Current Psoriasis Medicines?
Often triggered by stress, new studies are showing that psoriasis can be better managed by diet, oral health, and even cannabidiol.
The National Psoriasis Foundation shared information on a study from the Journal of Dermatological Science showcasing that, “CBD may offer therapeutic value for psoriasis by slowing the overgrowth of certain skin cells.”
A 2016 study published in the journal Current Clinical Pharmacology found similar results, citing that cannabinoids may be a positive addition to treatment for psoriasis.
Even better, a 2018 study did a sweeping review of prior research on cannabis’ role within dermatology and found, “cannabinoids have shown some initial promise as a therapy for a variety of skin diseases.” Their only concern was a lack of research in clinical trials, due to the Schedule 1 classification of the drug.
The National Psoriasis Foundation states that upwards of 8 million people have the auto-immune skin disorder. Often accompanied by arthritis, psoriasis not only causes scaling of the skin, but complications to fingernails as well.
Affecting everyone from children to adults, psoriasis can lead to anxiety and depression, as individuals with the skin disorder are often afraid of being ridiculed. Usually treated with Humira and Enbrel, psoriasis comes with a shocking price tag and complications that are often difficult to ignore.
A 2014 study published in the journal Drugs in Context found that Humira had a price tag upwards of $39,000, while Enbrel’s annual cost was around $46,000. Stelara, the most expensive drug, was found to cost over $53,000. As TNF blockers, while medications like Humira help against psoriasis, they can lower the body’s ability to fight infections and cause serious side effects.
Even more interesting, a September 2019 study in London found that, “A number of medications commonly prescribed by rheumatologists may interact with cannabidiol oil” (CBD oil). The most affected medicines appear to be corticosteroids (including hydrocortisone and prednisolone) since CBD, “is a potent inhibitor of CYP3A.” Put plainly, CBD may block the effects of the other medicine.
Image Credit: Aleksandr_Kravtsov | Getty Images via The Fresh Toast
Can CBD alone help psoriasis?
Often triggered by stress, new studies are showing that psoriasis can be better managed by diet, oral health, and even cannabidiol. The National Psoriasis Foundation shared information on a study from the Journal of Dermatological Science showcasing that, “CBD may offer therapeutic value for psoriasis by slowing the overgrowth of certain skin cells.”
A 2016 study published in the journal Current Clinical Pharmacology found similar results, citing that cannabinoids may be a positive addition to treatment for psoriasis. Even better, a 2018 study did a sweeping review of prior research on cannabis’ role within dermatology and found, “cannabinoids have shown some initial promise as a therapy for a variety of skin diseases.” Their only concern was a lack of research in clinical trials, due to the Schedule 1 classification of the drug.
While CBD and cannabis offer pain relief and psoriasis is often accompanied by rheumatoid arthritis, each individual must discuss the addition of any new medicine (including CBD and cannabis) with their care team. With new clinical trials for cannabinoids and psoriasis recruiting even now, promising cures may be on the horizon.
Posted by AGORACOM-JC
at 5:28 PM on Thursday, October 29th, 2020
SPONSOR POST:
WHY KWESST? HERE’S SOME GREAT REASONS
1. KWESST is a leader in defensive technologies that increase the capabilities of soldiers, including those of NATO and its allies.
2. These technologies make a critical difference to soldier safety and effectiveness.
3. The Leadership team experience spans decades and hundreds of millions of dollars in military and homeland security contracts.
4. KWESST develops next-generation systems for forces around the world, with a particular focus on special forces among NATO countries and their allies.
5. KWESST partners with globally recognized equipment manufacturers to integrate its systems into their solutions to create high value-add products for global customers.
Announced the elevation of its affiliation with SAMSUNG Electronics America Inc. to “USA Partner” status
KWESST will be employing the SAMSUNG S20TE tactical smart phone in the production version of the Company’s Tactical Awareness and Situational Control System (TASCS) and for its Integrated Fires Module (IFM) for networked targeting on soldiers’ weapons
SAMSUNG S20TE device, also known as the Galaxy S20 Tactical Edition, is the latest mission-ready military smartphone built and proven by operators in special operations for rapid information capture, sharing and analysis in diverse operating environments
6. KWESST provides small cap investors with a rare opportunity to invest in a high-growth, technology driven, global defence company with:
Tier-1 Customers
Global Customers
Proprietary Technologies
Diversified Products
Globally Renowned Executive Team With Massive Successful Track Records
—————–
Defense Market Size Anticipated To Exceed USD 10.5 Billion By 2023
Defense market size was valued around USD 6 billion in 2014 and is anticipated to exceed USD 10.5 billion by 2023, growing at a CAGR of over 6.1% from 2016 to 2023. The growth can be mainly attributed to increasing technological innovation and advancement. The technological improvements are expected to improvise the military power and thus resulting in making it stronger. Various nations are now concentrating on developing the protection systems for themselves as well as to trade with other militaries.
Proliferating security concerns among various nations and rising government spending in research and development activities is likely to propel the industry growth. Nations assessment of its security is mainly responsible for shaping its security system. As the country’s economy grows its security spending also increases. Nations are now retooling their fighting abilities towards more affordable and updated technology.
Countries such as China, Israel and Russia defense market see significant spending in improvising their resistance systems. As of 2015, U.S spends around 54% of its fiscal budget for military utilities and accounted for 37% of the overall industry share. It spends as much as USD 610 billion and ranks first in case of defense expenditure across the globe. Japan, China, United Kingdom, Russia, Germany, South Korea, France, Saudi Arabia and India collectively valued for USD 601 billion in 2015.
The global defense market is estimated to face two major challenges over the forecast period namely, profitability growth and cost cutting to maintain financial performance. In order to tackle these conditions several counties namely India is now focusing on defense foreign investments and technology platforms for increasing production operations in the country. As of 2015, The Ministry of Commerce and Industry (MC&I) has modified its FDI limit from 26% to 49% in order to improve country’s own security system. Moreover, declining resistance budgets accompanied by rising development costs is expected to hamper defense market growth from 2016 to 2023.
In addition, countries namely UAE, Saudi Arabia, India, South Korea, Japan, China and Russia exhibit potential growth prospects owing to threat from other countries. Defense companies are expected to witness huge growth opportunities owing to increasing investment in next generation ISR, unmanned combat land and sea vehicles, cognition & data analytics as well as improved precision strike with the assistance of non kinetic weapons. The defense market can be segmented on the basis of platform which includes airborne, naval and land based.
U.S. MDA (Missile Defense Agency) and Raytheon are jointly working on development of MOKV (Multi-Object Kill Vehicle) concept. These are specialized equipments that are likely to steer itself to the target and destroy the objects in space. In addition, India has test fired its AAD (advanced air defense) interceptor missile developed by DRDO (Defense Research and Development Organisation). It is a single-stage, anti-ballistic missile designed to suspend incoming missiles from an altitude of 30 kms. When integrated with Prithvi air defense missile, the experiment might result in two-tier ballistic missile defense system which is developed to intercept any threat from an altitude of 5000 kms.
Key industry participants in defense market share include Boeing, EADS/Airbus, United Technologies, Raytheon, Northrop Grumman and General Atomics Aeronautical Systems, ABG Shipyard Limited (ABG), Adcom Military Industries, Bharat Dynamics Limited, Brazilian Company Avionics Services, CADES Engineering Technologies Ltd, Cassidian Cyber Security, EBV Explosives Environmental Company, Direction des Constructions Navales Services (DCNS), BAE Systems Information and Electronic Systems Integration Inc. (US), EUREST Raytheon Support Services , European Advanced Technology S.A., Hispano-Suiza, HCL Aerospace & Defense and Advance Tech Control Pvt Ltd among others.
Posted by AGORACOM-JC
at 4:20 PM on Thursday, October 29th, 2020
SPONSOR:PlantX Life Inc. (VEGA:CSE) – The Digital Face of The Plant – Based Community. The company is aiming to be the most trusted online destination for the plant-based community and those interested in living a plant-based lifestyle which includes the following;
Plant Based Meal Delivery – 20 unique 100% plant based meals for home delivery
20,000 items including snacks, drinks and even chocolate
Plant Based …. PLANTS (It’s A BIG Business!)
Plant Based Pet foods
Plant Based Restaurant Locator
—————–
Veganuary Celebrates 1 Million Participant As Plant-Based Diet Goes Mainstream
Veganuary, the U.K.-based campaign encouraging people to eat vegan for the month of January, has just hit the 1 million supporter mark since its inception in 2014
The achievement is testament to the growing plant-based trend, especially in the wake of the coronavirus pandemic, which has sent consumers all over the world looking for healthier, more sustainable and safer alternatives to animal foods.
Veganuary, the U.K.-based campaign encouraging people to eat vegan for the month of January, has just hit the 1 million supporter mark since its inception in 2014. The achievement is testament to the growing plant-based trend, especially in the wake of the coronavirus pandemic, which has sent consumers all over the world looking for healthier, more sustainable and safer alternatives to animal foods.
Announced on Monday (October 26), Veganuary has welcomed its one millionth participant joining the movement to try veganism for 31 days. Since the campaign first began in 2014, it has attracted the support of big names, including television presenter Jasmine Harman, actor Peter Egan and renowned wildlife presenter Chris Packham.
Harman, who took part in the first-ever Veganuary six years ago, broadcasted a video message congratulating the charity on the milestone. “I feel very proud and very privileged to have been with Veganuary from the start and to be one of their ambassadors,” she said.
In its first year, Veganuary attracted just 3,300 supporters, but it quickly rose to fame as plant-based foods have come to garner greater spotlight in recent years as consumers begin to couple the environmental footprint and health impact of their food choices. The one million total includes the record-breaking 400,000 participants that joined the movement this year, a jump from the 250,000 figure in 2019, and 170,000 in 2018.
One million official Veganuary participants in just seven years is a huge achievement, but the momentum behind the plant-based revolution will see us hit two million in no time. Matthew Glover, Co-Founder & Chair of Veganuary
The real figure is likely to be much higher than one million, given that people around the world are believed to have taken part in the event without signing the official pledge online. A significant number have also continued their plant-based diet after the month of January. According to research conducted by data insights firm Kantar, the actual number of people who have participated without officially signing up is around ten times higher.
Commenting on the milestone, Matthew Glover, the co-founder and chair of the charity, said: “Now Veganuary is a bigger feature in the retail calendar than Christmas, reflecting the ever-increasing number of people choosing plant-based food.”
“One million official Veganuary participants in just seven years is a huge achievement, but the momentum behind the plant-based revolution will see us hit two million in no time.”
Signatories to the pledge have come from every single country in the world apart from North Korea, Vatican City and Eswatini. In 2020, the most growth in supporters was recorded in Latin America, followed by India – two major markets where plant-based foods have experienced a surge in demand.
All over the world, consumers have been shifting towards plant-based foods more than ever before, particularly in the wake of the pandemic, which has exposed the vulnerabilities and dangers of the animal meat supply chain. With the trend firmly in the mainstream, food giants have been scrambling to tap into the market – the latest research shows that almost 40% of the biggest food manufacturers and retailers in the world now have dedicated plant-based teams.
Plant-based meat makers have also celebrated a big win in Europe just last week, when EU leaders prevented a proposal that would ban plant-based alternatives from using “meaty” terms like sausages or burgers on their labels.
Posted by AGORACOM
at 1:28 PM on Thursday, October 29th, 2020
(CSE: TRIP)
Red Light Holland’s iMicrodose packs are Available on Shelves in the Netherlands (18+) and online plus their Science and Innovation Division, Scarlette Lillie, is taking notice in the Longevity field, via their Jinfiniti arrangement.
It appears as if, Scarlette Lillie Science and Innovation’s goal is to support science and medical research without needing to raise 100’s millions of dollars while focusing on the digital experience and potential opt-in user data collection.
Red Light Holland and Scarlette Lillie is focused on education and information plus adult-responsible use of their iMicrodose packs.
Joined the Medical Psychedelics Working Group
a consortium of drug science experts, leading academics and researchers, policy specialists and industry partners
Scarlette Lillie and Jinfiniti Precision Medicine
This relationship with Jinfiniti may allow Scarlette Lillie to add a novel component to expected clinical studies for psilocybin and truffles.
The knowledge that comes from this has the potential to not only influence the outcome of clinical studies but can also potentially lead to novel treatments for several disorders.
Virtual Reality Shopping Experience
Red Light Holland is creating a virtual reality shopping experience module, intended to explain the effects of microdosing of magic truffles on the human brain, as well as a virtual reality avatar that is centered around Red Light Holland’s brand.
The VR Module is expected to be completed in Q4 2020,
Educating and enabling individuals to make reasoned, informed decisions with respect to magic truffles and other psychedelic substances,
Enabling Red Light Holland to gather valuable data on user experience of synesthesia, loss of autonomy and suggestibility to inform further study and research in the psychedelic space.
The VR Avatar, which is expected to be completed in Q3 2020, is expected to assist Red Light Holland’s larger efforts towards reducing the stigma associated with, among other things, magic truffles and other psychedelic substances.
Red Light Holland’s Growth Potential
TRIP is established to grow, distribute and market a magic truffles to the legal, recreational market within the Netherlands
Red Light Holland has reached a Distribution Arrangement for iMicrodose Packs with a total of 8 Smart Shops Netherlands and expects that number to grow rapidly.
Red Light Holland iMicrodose Packs are currently available in 3 Smartshops and the rest are expected to be in Smartshops by the end of October, 2020
Red Light Holland iMicrodose Packs are available to the Netherlands, Adult market online at www.iMicrodose.nl and are offering a unique subscription model.
The sales and growth evolution of Red Light is just beginning
“This is just another example on how aggressive we are by immediately increasing the ability for consumers, all over the Netherlands, to purchase our iMicrodose packs powered by Red Light Holland. ” Todd Shapiro, CEO and Director of Red Light Holland.
Red Light (to the best of our research) is the first public company selling psychedelic products on the market
Responsibility Toward Consumption
Responsible use requires users who are at a minimum 18 years old.
Red light is a self-regulated company and in accordance with the highest standards and compliance with all applicable laws.
Red Light Holland’s team includes Bruce Linton as their Chair of the Advisory Board, Tony Clement (former Canadian Health Minister) and World Famous Entertainer Russell Peters.
Red Light Holland has been featured in vice.com – www.Hightimes.com – the New York Observer – and mentioned on The Joe Rogan Experience.
Former Top Rated Host, CEO Todd Shapiro is clearly using his deep rooted celebrity connections to get incredible exposure on the Company.
This earned media to such a large audience is impressive for any small cap Company
Red Light Holland’s current market cap is approximately 20 million and appears to be low when comparing them to their peers, considering they currently have a product on shelves, while supporting science and innovation intelligently.
Posted by AGORACOM
at 8:54 AM on Thursday, October 29th, 2020
VANCOUVER, British Columbia, Oct. 29, 2020 (GLOBE NEWSWIRE) — Candente Gold Corp. (TSXV:CDG) (“Candente Gold” and/or the “Company”) is pleased to announce that high grade gold and silver has been sampled on the Cocula project.
As reported in News Release dated, October 22nd, 2020, samples collected to check historical reporting confirmed grades of 5.663 grams per tonne (“g/t”) gold over 6 metres and 4.322 g/t gold over 8 metres in quartz breccia bodies which we understand are typical throughout the deposit.
In addition, higher grades of 59.0 g/t gold and 729 g/t silver have been found in a selected sample over 10 centimetres (“cm”) in the hanging wall of a quartz vein-breccia structure near the portal of a collapsed adit. We understand mineralization was previously exploited from this adit on a small scale using a flotation recovery process but the Company has not found any formal production records. The mineralization in the high grade sample is described as dark grey to milky white banded quartz in vein and breccia with galena, pyrite and quartz crystals filling open spaces. A channel sample collected over 0.75 m adjacent to the selected sample and including part of the hanging wall, only returned 0.182 g/t gold and 18.9 g/t silver. The channel sample comprised milky white and gray to dark gray quartz breccia vein with fine grained pyrite, +1% galena and trace malachite. The Company understands that the high grades are coming from a bonanza zone for which we have no idea of the size or extent yet. Due to the nature of the high grades, the bonanza zone samples were check assayed in a second laboratory. The two laboratories used are the Alti Plano Gold Silver laboratory in Matehualas, San Luis Potosi, Mexico owned by Reyna Mining and Inspectorate Laboratory owned by Bureau Veritas who prepare their samples in Durango, Mexico and conduct sample analyses in Vancouver, Canada.
Base metal assays and multi-element ICP analyses are still pending for the rock check samples as are results from preliminary metallurgical testing.
The due diligence work is being conducted by Ing. Humberto Hernandez, Geological Engineer, member of Asociación de Ingenieros Mineros, Metalúrgistas y Geólogos de México and Ing. Gerardo Moreno, Geological Engineer and Miner, of Grupo Constructor Germo based in Durango, Mexico.
The Cocula Project area is located within the Ameca Mining District of Jalisco State which is home to Agnico Eagle’s El Barqueño Project and Endeavor Silver’s Terronera Project.
Please see News Releases No. 084 and 086 dated September 10th, and October 22nd, 2020 and http://www.candentegold.com/s/cocula.asp for further details on the Cocula Project.
About Candente Gold
Candente Gold has launched a comprehensive growth strategy to build a cash flowing business platform and gain access to properties with near surface exploration potential while maintaining El Oro as its flagship asset and an integral part of the overall growth strategy. The acquisition of the SDA Plant, the El Dorado historic mines and the Cocula Project signifies an important first step.
The financial benefits from Western Mexico operations and the addition of specialized personnel will translate across platforms to strengthen our efforts to explore and potentially mine. The Company is currently evaluating other properties that are complimentary to the SDA plant, El Dorado and the Cocula Project.
El Oro is a district scale gold project encompassing a well-known prolific high-grade gold dominant gold-silver epithermal vein system in Mexico. The project covers 20 veins with past production and more than 57 veins in total, from which approximately 6.4 million ounces of gold and 74 million ounces of silver were reported to have been produced from just two of these veins (Ref. Mexico Geological Service Bulletin No. 37, Mining of the El Oro and Tlapujahua Districts. 1920, T. Flores*)
Modern understanding of epithermal vein systems indicates that several of the El Oro district’s veins hold excellent discovery potential, particularly below and adjacent to the historic workings of the San Rafael Vein, which was mined to an average depth of only 200 metres.
Joanne C. Freeze, P.Geo., President, CEO and Director and Matthew Melnyk, CPG., Director Operations and Director are Qualified Persons as defined by National Instrument 43-101 for the projects discussed above, however they have not been able to visit the Cocula Project recently due to COVID virus travel restrictions. The work discussed in the News Release is either historical and documented by public records or conducted by Mexican professionals with qualifications similar to those of QP’s registered in Canada. Ms. Freeze and Mr. Melnyk have reviewed and approved the contents of this release.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
Forward-looking Information
This news release may contain forward-looking information (as such term is defined under Canadian securities laws) including but not limited to information regarding the potential for and other statements that are not historical facts. While such forward-looking information is expressed by Candente Gold in good faith and believed by Candente Gold to have a reasonable basis, they address future events and conditions and are therefore subject to inherent risks and uncertainties including those set out in Candente Gold’s MD&A. Factors that cause the actual results to differmaterially from those in forward-looking information include, without limitation, gold prices, results of exploration and development activities, regulatory changes, defects in title, availability of materials and equipment, timeliness of government approvals, potential environmental issues, availability of capital and financing and general economic, market or business conditions. Candente Gold expressly disclaims any intention orobligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except in accordance with applicable securities laws.
On behalf of the Board of Candente Gold Corp. “Joanne Freeze” P.Geo. President, CEO and Director
For further information please contact: Joanne Freeze President & CEO Tel: + 1 (604) 689-1957
Posted by AGORACOM-JC
at 7:39 AM on Thursday, October 29th, 2020
Else has successfully completed a second commercial manufacturing run, 300% larger than the initial production run, and will commence a third manufacturing run in early November
This planned production run is expected to be 200% larger than the second run, and 600% larger than the inaugural one
Successful scale-up of production while maintaining a consistent and high-quality product is a major inflection point in the Company’s go-to market strategy
Else will generate additional inventory to service the Company’s expansion in the U.S. market as it rapidly expands into retail distribution, and scales its online sales
VANCOUVER, BC , Oct. 29, 2020 – ELSE NUTRITION HOLDINGS INC. (TSX-V: BABY) (OTCQX: BABYF) (FSE: 0YL) (” Else ” or the ” Company “), a commercial stage developer of plant-based alternatives to dairy-based baby nutrition, is pleased to provide an update on its North American product launch of its plant-based Toddler Nutrition product.
Else has successfully completed a second commercial manufacturing run, 300% larger than the initial production run, and will commence a third manufacturing run in early November. This planned production run is expected to be 200% larger than the second run, and 600% larger than the inaugural one. Successful scale-up of production while maintaining a consistent and high-quality product is a major inflection point in the Company’s go-to market strategy. As a result, Else will generate additional inventory to service the Company’s expansion in the U.S. market as it rapidly expands into retail distribution, and scales its online sales.
“We are encouraged by the early response to our long awaited product launch, and equally pleased to have to ramp up our inventory as we continue to see strong demand for our novel, clean-label, plant-based Toddler Nutrition product,” said Mrs. Hamutal Yitzhak , CEO and Co-Founder of Else. “We are grateful for the very positive daily feedback from parents across North America , and look forward to bringing the product to store shelves soon. Additionally, a consistent, high quality and scalable manufacturing process is a critical pillar of our business – we are pleased to have successfully completed two commercial scale runs and look forward to exponentially scaling the next one.
Else has completed the setup and order automation processes by signing up with a third-party logistics company. This provider has warehouses across the U.S. and Canada which will support Else’s E-commerce sales. Online order shipments have already commenced.
Else Nutrition’s Plant-Based Complete Nutrition for Toddlers & Babies (12+ mo.) is now available for sale on Else’s e-store at elsenutrition.com , and on Amazon.com. The Company also recently added subscription plans on its e-store.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .
For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Posted by AGORACOM-JC
at 7:35 AM on Thursday, October 29th, 2020
Kontrol BioCloud a Safe Space Technology™
Provides an update on lower detection limits and commercialization.
“We are pleased to continue to advance towards production of BioCloud units in November,” says Paul Ghezzi, CEO Kontrol. “The lower detection limit is an important benchmark to provide potential customers with the operating sensitivity of BioCloud.”
As part of its commercialization of the BioCloud technology, Kontrol has currently established a lower detection limit of 50 SARs-COV-2 virus particles
This represents a sufficient sensitivity to the SARS COV-2 virus for commercialization
TORONTO, ON / October 29, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“) is pleased to provide an update on its Kontrol BioCloud (or “BioCloud“) technology. As initially referenced in the press release from September 10, 2020 Kontrol is providing an update on lower detection limits and commercialization.
Lower Detection Limit
“We are pleased to continue to advance towards production of BioCloud units in November,” says Paul Ghezzi, CEO Kontrol. “The lower detection limit is an important benchmark to provide potential customers with the operating sensitivity of BioCloud.”
As part of its commercialization of the BioCloud technology, Kontrol has currently established a lower detection limit of 50 SARs-COV-2 virus particles. This represents a sufficient sensitivity to the SARS COV-2 virus for commercialization.
The determination of lower detection limit was tested under independent laboratory conditions over multiple tests. The BioCloud virus collector was exposed to live SARs-COV-2 virus (virus that causes COVID-19) at multiple levels of virus ranging from 10,000, 5,000, 1,000, 100, 50 and 5 viruses. These tests were conducted multiple times to ensure repeatability of the response, and under laboratory conditions the detection of the live SARs-COV-2 virus was repeatably identified at 50 virus particles.
Commercialization
Based on feedback from potential customers and potential distribution channels Kontrol is seeking multiple certifications concurrently to meet regional requirements. These include CSA, CE and UL. CSA is a Canadian certification; CE mainly applies to European electronic products and UL is typically required in the USA.
Balance Sheet
Kontrol currently has approximately $3.0 Million of cash on hand as of October 28th, 2020 and has sufficient resources to complete the commercialization of BioCloud.
National Research Council of Canada
Kontrol has submitted all of its required research and files for potential National Research Council of Canada funding.
About Kontrol BioCloud
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others. It can be an important technology which supports the entire system of individual testing and contact tracing.
The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).
About Kontrol Energy
Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.
Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at: www.sedar.com
For further information, contact:
Paul Ghezzi, Chief Executive Officer [email protected] or [email protected] Kontrol Energy Corp., 180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8 Tel: 905.766.0400, Toll free: 1.844.566.8123
Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.
However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.
Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.
